See also this year's filing and all EDGAR filings for this company.
PDF Report 0001600132_2018_Bellerophon_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001600132')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001600132, Bellerophon Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 35,580,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,026,000 |
| 3 | remainder_Assets | 204,000 |
| 4 | LiabilitiesCurrent | 7,079,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 32,325,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,745,000 |
| 9 | ResearchAndDevelopmentExpense | 17,854,000 |
| 10 | remainder_Expenses | 30,403,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 184,000 |
| 13 | remainder_ComprehensiveNetIncome | -4,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 36,810,000 |
| 1 | Liabilities | 39,404,000 |
| 2 | Expenses | 55,002,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -2,594,000 |
| 5 | NetIncome | -54,818,000 |
| 6 | ComprehensiveNetIncome | -54,820,000 |
| 7 | BaseVar | 65,702,000 |
| 8 | EconomicCapitalRatio | -1.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
